These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30822713)

  • 1. Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.
    Spinello A; Martini S; Berti F; Pennati M; Pavlin M; Sgrignani J; Grazioso G; Colombo G; Zaffaroni N; Magistrato A
    Eur J Med Chem; 2019 Apr; 168():253-262. PubMed ID: 30822713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in computational design of potent aromatase inhibitors: open-eye on endocrine-resistant breast cancers.
    Spinello A; Ritacco I; Magistrato A
    Expert Opin Drug Discov; 2019 Oct; 14(10):1065-1076. PubMed ID: 31339372
    [No Abstract]   [Full Text] [Related]  

  • 3. Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.
    Wang Q; Liberti MV; Liu P; Deng X; Liu Y; Locasale JW; Lai L
    Cell Chem Biol; 2017 Jan; 24(1):55-65. PubMed ID: 28042046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational approaches elucidate the allosteric mechanism of human aromatase inhibition: a novel possible route to Small-molecule regulation of CYP450s activities?
    Sgrignani J; Bon M; Colombo G; Magistrato A
    J Chem Inf Model; 2014 Oct; 54(10):2856-68. PubMed ID: 25178092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
    Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
    Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridine-substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation.
    Ertas M; Sahin Z; Berk B; Yurttas L; Biltekin SN; Demirayak S
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700272. PubMed ID: 29522642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
    Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
    Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
    Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
    J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of new steroidal inhibitors of estrogen synthase (aromatase).
    Parish EJ; Li S; Rao Z
    Lipids; 2000 Mar; 35(3):271-7. PubMed ID: 10783004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
    Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
    Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women.
    Avvaru SP; Noolvi MN; Aminbhavi TM; Chkraborty S; Dash A; Shukla SS
    Mini Rev Med Chem; 2018; 18(7):609-621. PubMed ID: 29090666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy.
    Caciolla J; Martini S; Spinello A; Belluti F; Bisi A; Zaffaroni N; Magistrato A; Gobbi S
    Eur J Med Chem; 2022 Dec; 244():114802. PubMed ID: 36240547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer.
    Mishra K; Verma SK; Ratre P; Banjare L; Jain A; Thareja S; Jain AK
    Anticancer Agents Med Chem; 2021; 21(9):1191-1199. PubMed ID: 32842946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, in vitro and in silico studies of some novel thiazole-dihydrofuran derivatives as aromatase inhibitors.
    Osmaniye D; Görgülü Ş; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Bioorg Chem; 2021 Sep; 114():105123. PubMed ID: 34214753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic and Inhibition Mechanism of Human Aromatase (CYP19A1) Enzyme. A Computational Perspective from QM/MM and Classical Molecular Dynamics Simulations.
    Sgrignani J; Cavalli A; Colombo G; Magistrato A
    Mini Rev Med Chem; 2016; 16(14):1112-24. PubMed ID: 27337972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting allosteric sites of human aromatase: a comprehensive
    Alhadrami HA; Sayed AM; Melebari SA; Khogeer AA; Abdulaal WH; Al-Fageeh MB; Algahtani M; Rateb ME
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1334-1345. PubMed ID: 34139914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.
    Ananth AH; Manikandan N; Rajan RK; Elancheran R; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Kabilan S
    Chem Biodivers; 2020 Feb; 17(2):e1900659. PubMed ID: 31995280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells.
    Gupta A; Mehta R; Alimirah F; Peng X; Murillo G; Wiehle R; Mehta RG
    J Steroid Biochem Mol Biol; 2013 Jan; 133():30-42. PubMed ID: 22939887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase and breast cancer.
    Brodie A; Sabnis G; Jelovac D
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):97-102. PubMed ID: 17113978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.